Abdullah Alhammad

681 total citations
41 papers, 406 citations indexed

About

Abdullah Alhammad is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Surgery. According to data from OpenAlex, Abdullah Alhammad has authored 41 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Applied Microbiology and Biotechnology and 6 papers in Surgery. Recurrent topics in Abdullah Alhammad's work include Antibiotic Use and Resistance (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Patient Safety and Medication Errors (4 papers). Abdullah Alhammad is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Patient Safety and Medication Errors (4 papers). Abdullah Alhammad collaborates with scholars based in Saudi Arabia, United States and Kuwait. Abdullah Alhammad's co-authors include Kristine C. Willett, Sultan Alghadeer, Salmeen D. Babelghaith, Mohammed N. Al-Arifi, Thamer A. Almangour, Hadeel Alkofide, Mushira A. Enani, Mohammad H. Aljawadi, Ohoud Aljuhani and Khalid Al Sulaiman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Critical Care Medicine.

In The Last Decade

Abdullah Alhammad

36 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Alhammad Saudi Arabia 10 102 76 72 49 48 41 406
Mera Ababneh Jordan 13 118 1.2× 94 1.2× 48 0.7× 50 1.0× 33 0.7× 47 431
Cenk Aypak Türkiye 15 64 0.6× 247 3.3× 79 1.1× 38 0.8× 39 0.8× 76 794
Yanhong Hu China 14 198 1.9× 175 2.3× 77 1.1× 45 0.9× 79 1.6× 54 609
Saleh Alghamdi Saudi Arabia 16 150 1.5× 114 1.5× 67 0.9× 68 1.4× 188 3.9× 63 716
Nilam Patel United States 8 230 2.3× 160 2.1× 39 0.5× 36 0.7× 67 1.4× 15 517
Darshana Bennadi India 9 259 2.5× 87 1.1× 41 0.6× 144 2.9× 43 0.9× 32 737
Verica Ivanovska Netherlands 10 168 1.6× 106 1.4× 34 0.5× 59 1.2× 37 0.8× 14 573
Çağrı Büke Türkiye 11 211 2.1× 171 2.3× 136 1.9× 36 0.7× 111 2.3× 22 550
A. Pannatier Switzerland 12 87 0.9× 49 0.6× 53 0.7× 113 2.3× 19 0.4× 28 595
Michael F. Canarie United States 10 91 0.9× 97 1.3× 42 0.6× 14 0.3× 59 1.2× 16 451

Countries citing papers authored by Abdullah Alhammad

Since Specialization
Citations

This map shows the geographic impact of Abdullah Alhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Alhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Alhammad more than expected).

Fields of papers citing papers by Abdullah Alhammad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Alhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Alhammad. The network helps show where Abdullah Alhammad may publish in the future.

Co-authorship network of co-authors of Abdullah Alhammad

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Alhammad. A scholar is included among the top collaborators of Abdullah Alhammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Alhammad. Abdullah Alhammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aljawadi, Mohammad H., et al.. (2024). Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study. Open Forum Infectious Diseases. 11(3). ofae059–ofae059. 9 indexed citations
3.
Aljawadi, Mohammad H., et al.. (2024). Understanding the Quality of Life Among Patients With Cancer in Saudi Arabia: Insights From a Cross-Sectional Study. Cancer Control. 31. 2925681061–2925681061.
4.
Hazwani, Tarek, et al.. (2024). Diffuse axonal injury on magnetic resonance imaging and its relation to neurological outcomes in pediatric traumatic brain injury. Clinical Neurology and Neurosurgery. 237. 108166–108166. 7 indexed citations
5.
Aljawadi, Mohammad H., et al.. (2024). Quality of life tools among patients on dialysis: A systematic review. Saudi Pharmaceutical Journal. 32(3). 101958–101958. 7 indexed citations
6.
Alhammad, Abdullah, et al.. (2023). Characteristics of Critical Care Pharmacy Services in Saudi Arabia. Journal of Multidisciplinary Healthcare. Volume 16. 3227–3234. 2 indexed citations
7.
8.
9.
Alhammad, Abdullah, et al.. (2023). Excessively High Chronic Propranolol Overdose in Infantile Hemangioma: A Case Report. American Journal of Case Reports. 24. e941765–e941765. 1 indexed citations
10.
Bawazeer, Ghada, et al.. (2022). Crossword puzzle as a learning tool to enhance learning about anticoagulant therapeutics. BMC Medical Education. 22(1). 267–267. 14 indexed citations
11.
Almuqbil, Mansour, et al.. (2022). The role of drug information centers to improve medication safety in Saudi Arabia - a study from healthcare professionals' perspective. Saudi Pharmaceutical Journal. 30(4). 377–381. 4 indexed citations
12.
Alshaya, Abdulrahman, et al.. (2021). Critical care pharmacy in Saudi Arabia: Historical evolution and future directions—A review by the Critical Care and Emergency Medicine Pharmacy Specialty Network at the Saudi Society of Clinical Pharmacy. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(11). 1428–1437. 2 indexed citations
13.
Almangour, Thamer A., Abdullah A. Alhifany, Khalid Eljaaly, et al.. (2021). Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study. International Journal of Infectious Diseases. 108. 406–412. 15 indexed citations
14.
Sulaiman, Khalid Al, Ohoud Aljuhani, Khalid Bin Saleh, et al.. (2021). Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Scientific Reports. 11(1). 17648–17648. 41 indexed citations
15.
Alkofide, Hadeel, et al.. (2020). Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes – A Retrospective Cohort Study. Infection and Drug Resistance. Volume 13. 4653–4662. 59 indexed citations
16.
Almodaimegh, Hind, et al.. (2020). PBI12 Budget Impact Analysis of Baricitinib for the Management of Moderate-to-Severe Rheumatoid Arthritis in the Kingdom of Saudi Arabia. Value in Health. 23. S412–S412. 1 indexed citations
17.
Alhammad, Abdullah, et al.. (2019). Trends in drug information education in different first- professional degree pharmacy programmes in the Arabian Gulf region. Pharmacy Education. 19(1). 49–55. 1 indexed citations
18.
Mayet, Ahmed Y., et al.. (2018). Rivaroxaban prescribing in a Saudi tertiary care teaching hospital. Saudi Pharmaceutical Journal. 26(6). 775–779. 6 indexed citations
19.
Alghadeer, Sultan, et al.. (2018). Self-medication with antibiotics in Saudi Arabia. Saudi Pharmaceutical Journal. 26(5). 719–724. 72 indexed citations
20.
Roberts, Russel J., et al.. (2017). A survey of critical care nurses’ practices and perceptions surrounding early intravenous antibiotic initiation during septic shock. Intensive and Critical Care Nursing. 41. 90–97. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mera Ababneh Breakdown of academic impact, for papers by Cenk Aypak Breakdown of academic impact, for papers by Yanhong Hu Breakdown of academic impact, for papers by Saleh Alghamdi Breakdown of academic impact, for papers by Nilam Patel Breakdown of academic impact, for papers by Darshana Bennadi Breakdown of academic impact, for papers by Verica Ivanovska Breakdown of academic impact, for papers by Çağrı Büke Breakdown of academic impact, for papers by A. Pannatier Breakdown of academic impact, for papers by Michael F. Canarie
Rankless by CCL
2026